01
To investors
The limit of this technology was never imagination but capital and infrastructure. Help carry the strong signals already observed into the language of global clinical research and into industry.
08 / HEALTHCARE 4.0 ESSENTIAL
Earth, people and nature
share one destiny
Shorter years of illness, longer years of health. The recovery of people and the recovery of the land, achieved together. That is what I want to do with GRBM.
In plain words
This site was not made to introduce a single product. It is the record of more than 20 years spent trying to understand the ecological principles by which nature has always worked — rather than taking nature apart and dominating it — and to build them into industry. It is a proposal to industrialize the answer nature already held.
For 20 years I have listened to the conversation between Korea's native plants, their lactobacilli and human cells. And I made a material that can bring to everyone, regardless of age, the mechanism of life a mother gives her unborn child. I am convinced of GRBM.
But technology cannot change the world alone. Good technology that stays in the lab remains only a possibility, and a good philosophy that never becomes an industrial structure never becomes social change. It is time to begin the era of nature-based eco-bio. I am looking for a partner to grow the world's first genuine eco-bio platform technology together.
The HEALTHCARE 4.0 essential,
Green Red BIO Metabolome
In an age when AI reads the body, food the body recognizes changes it. The only process that makes that food is VPMI.
THREE REQUESTS
Three requests
02
To policymakers
Metabolic rights and a Korean 10th-order industrial ecosystem are a path to balanced national development and climate response together. The technology and the industry are already here.
03
To everyone
We become what we eat. Join in restoring the connection between plants, microbes and ourselves.
THE BROKEN CONNECTION
Not separate problems,
but one weakened connection
Cancer, dementia, chronic illness, depression, obesity, food crises, climate change, biodiversity loss, ageing and soaring medical costs are not problems of separate fields. They can be seen as the result of a weakened metabolic connection between people and nature. Modern medicine has suppressed symptoms, modern agriculture has raised yields and modern industry has traded emission rights. But nature works not when it is taken apart, but when it is connected.
The essence of this technology is not imitating nature. It lies in turning into an industrial platform the way nature has exchanged life information for billions of years, the mutualism of plants and microbes, and the flow of metabolites human cells can recognize. GRBM is neither a simple extract nor a single-ingredient material. It is an eco-bio operating system combining plant resources, Vital Probiotics, VPMI-CM, metabolic processes, quality data, product technology, service models and AI-based personalized care.
So the important question now goes beyond "Is this technology possible?" What matters more is who will use it, with what philosophy, at what scale and with what social responsibility.
THE ROLE OF CAPITAL
Capital with a lasting conviction
is the final driving force
What is needed now is capital that accepts a nature-based ecological approach not as an ideal but as a realistic industrial solution for the age of climate change. GRBM is an ingredient platform and a manufacturing platform, a product portfolio and a service system, a data-accumulation structure and, in the long run, a technology asset that extends into bio-materials and drug-candidate materials. And this business connects human health, food, agriculture, environment, data, medical services and the response to ageing within one ecosystem.
K-ECO BIO 10 is its industrial expression. When Korea's plant resources and smart farms, VPMI-CM and GRBM manufacturing, K-Bio Food, K-Beauty, Bio Healthcare Services, AI Health, data centres and global logistics connect as one, Korea can become a country that exports not products but an eco-bio industrial ecosystem. Not defensive ESG that reacts to environmental regulation, but Positive Green, which turns the climate crisis into an opportunity for growth.
The planet is warming, food systems are shaking, medical systems are growing heavier, and people live longer but are ill for longer. Such an age needs not capital that chases only short-term returns, but capital that designs healthy human lives and the future of industry together, out of a firm conviction about a sustainable planet. This technology was born from one developer's persistent research and real-world application, but it must no longer stay in one person's hands.
THE LAST MESSAGE
This is an investment not in one company,
but in the way we reconnect
- GRBMAn attempt to industrialize the answer nature already held
- VPMIThe technology that realizes that answer
- K-ECO BIO 10The structure through which that technology extends into society and industry
- CapitalCapital with a lasting conviction is the final force that makes all of this real
What we want to build together is not a bigger company. It is a society with access to a healthier metabolic environment, a plant-based industry that survives climate change, lives that can design recovery outside the hospital, and a future in which nature and technology work together rather than against each other. I hope this technology will start in Korea and go out into the world. Its starting point is Uljin, Gyeongsangbuk-do.
This investment decision is an investment in the way people and nature reconnect in the age of climate change, and in helping humanity move beyond "a life of being treated" toward "a life that designs recovery".
29 May 2026 · Wooyoung Nam, CEO and Developer, Elan Vital BIO Co., Ltd.
Read moreCloseLet us verify my conviction together
The developer's conviction began in long research and field observation. Now I want to examine the original records, samples and analytical methods together and develop them into reproducible evidence. This site is a proposal for that collaboration.
-
01
INDUSTRIALIZE
Connect demand and evidence at each stage of life and industrialize them
-
02
EXTRACT
Separate, purify and identify the solid fractions and study their functions
-
03
VERIFY
Design independent analysis, non-clinical and clinical verification step by step
Contact us about investment and partnership →
FROM KOREA TO THE WORLD — Elan Vital BIO Co., Ltd. · grbm@elanvitalbio.biz · +82-10-4229-9171. Closing words: Complete Proposal, Chapter 16 "Closing Words".
PARTNERSHIP · INVESTMENT
The world's first true eco-bio platform technology —
we are looking for the one partner
After signing an NDA you can review the materials, then verify the original records and the process in person during on-site due diligence in Uljin, Gyeongsangbuk-do, Korea.